Science Explorer Back to mapMap
Discussion
Researcher · PharmaMar (Spain) · Spain

Sergio A. Szyldergemajn

Sergio A. Szyldergemajn publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Cancer Treatment and Pharmacology, Lung Cancer Research Studies and Cancer therapeutics and mechanisms.

ORCID 0009-0009-0223-5691 OpenAlex
World rank
#3,701,159
of 7,710,434 ranked researchers
Rank in Spain
#84,070
of 204,306
Works
56
Citations
610
Citations per work
10.9
h-index
12
i10-index 12Top 48% in Oncology

What does Sergio A. Szyldergemajn research?

Sergio A. Szyldergemajn's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (25%), Chemistry (4%).

Life Sciences25%Physical Sciences4%Health Sciences49%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2849.3%
    1. Biochemistry, Genetics and Molecular Biology1425.3%
  1. Everything else1221.5%
    1. Chemistry23.9%
  1. 1Oncology34% of their works
  2. 2Molecular Biology18% of their works
  3. 3Pulmonary and Respiratory Medicine11% of their works
  4. 4Cancer Research7% of their works
  5. 5Organic Chemistry4% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Sergio A. Szyldergemajn's research?

The keywords of their largest research topics: Chemotherapy, Targeted Therapy, Clinical Trials, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Genomic Profiles, Small-Cell Lung Cancer and DNA.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Chemotherapy273 topics
  2. Targeted Therapy233 topics
  3. Clinical Trials172 topics
  4. Chemotherapy-Induced Peripheral Neuropathy131 topic
  5. Taxanes131 topic
  6. Genomic Profiles121 topic
  7. Small-Cell Lung Cancer121 topic
  8. DNA91 topic
  9. Topoisomerases91 topic
  10. Cancer Genomics61 topic
  11. Cetuximab61 topic
  12. Fibroblast Activation Protein61 topic
  13. KRAS Mutations61 topic
  14. Mutational Signatures61 topic
  15. Tumor Microenvironment61 topic
  16. ALK Inhibitors51 topic
  17. EGFR Mutations51 topic
  18. Glycans41 topic
  19. Glycosylation41 topic

Where does Sergio A. Szyldergemajn work?

Sergio A. Szyldergemajn's main affiliation in the publication record is PharmaMar (Spain), Spain.

How many publications and citations does Sergio A. Szyldergemajn have?

OpenAlex counts 56 works and 610 citations for Sergio A. Szyldergemajn, an h-index of 12, ranking #3,701,159 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sergio A. Szyldergemajn. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.